Safety of Romiplostim (Nplate®) Following UCBT

NCT02046291 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Malignancies

Interventions

DRUG: Romiplostim

Sponsor

Masonic Cancer Center, University of Minnesota